Co-targeting VEGF and PD-(L)1 in gastrointestinal cancers: biology, clinical landscape, and therapeutic frontiers
Cancer Treatment Reviews · 2026-11 · 103246
DOI: 10.1016/j.ctrv.2026.103246 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Treatment Reviews, 2026-11. Verfasst von George Laliotis und 3 weiteren Autor:innen. Die Arbeit nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Laliotis, G., Pourbahrighesmat, S., Tojjari, A., & Saeed, A. (2026). Co-targeting VEGF and PD-(L)1 in gastrointestinal cancers: biology, clinical landscape, and therapeutic frontiers. Cancer Treatment Reviews, 103246. https://doi.org/10.1016/j.ctrv.2026.103246
Vancouver
Laliotis G, Pourbahrighesmat S, Tojjari A, Saeed A. Co-targeting VEGF and PD-(L)1 in gastrointestinal cancers: biology, clinical landscape, and therapeutic frontiers. Cancer Treatment Reviews. 2026:103246. doi:10.1016/j.ctrv.2026.103246
BibTeX
@article{Laliotis2026,
author = {Laliotis, George and Pourbahrighesmat, Shamimeh and Tojjari, Alireza and Saeed, Anwaar},
title = {Co-targeting VEGF and PD-(L)1 in gastrointestinal cancers: biology, clinical landscape, and therapeutic frontiers},
journal = {Cancer Treatment Reviews},
year = {2026},
pages = {103246},
doi = {10.1016/j.ctrv.2026.103246}
}
EUVIMED